| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/01/2014 | US20140120035 RS7 Antibodies |
| 05/01/2014 | US20140116916 Therapy for Constipation |
| 04/30/2014 | EP2725037A1 Monoclonal antibodies binding canine CD20 |
| 04/30/2014 | EP2724729A1 Apoptosis-inducing agent |
| 04/30/2014 | EP2724720A1 Compositions of phenylephrine useful for treatment of respiratory illness |
| 04/30/2014 | EP2723337A1 Treatment of hepatitis c virus |
| 04/30/2014 | EP2723330A1 Vasoconstrictor-containing agent for combination therapy |
| 04/30/2014 | EP2723328A1 Combination treatment comprising a hdac6 inhibitor and an akt inhibitor |
| 04/30/2014 | CN103764676A Fusion gene of KIF5B gene and RET gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 04/30/2014 | CN103764165A Drug for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor GC-A agonist and GC-B agonist |
| 04/30/2014 | CN103764144A Synergistic combinations of pi3k- and mek-inhibitors |
| 04/30/2014 | CN103751857A Drug-loaded silica embolism microsphere and preparation method thereof |
| 04/30/2014 | CN103751811A Diagnosis and treatment integrated bovine serum albumin anticancer nanoparticle and preparation method thereof |
| 04/30/2014 | CN103751809A Method for analyzing quality safety of traditional Chinese medicine injection and medicine preparation |
| 04/30/2014 | CN103751795A Preparation and application of hyaluronic acid-antitumor drug conjugate and composite nanoparticle composition |
| 04/30/2014 | CN103751784A Double-layer tablet comprising proton pump inhibitor |
| 04/30/2014 | CN103751783A Function of IRF1 in aortic constriction disease and application of inhibitor thereof |
| 04/30/2014 | CN103751782A New application of weakly alkaline solution |
| 04/30/2014 | CN103751781A Composition for preventing recurrence of stroke |
| 04/30/2014 | CN103751315A Traditional Chinese medicine extract capable of resisting fibrosis and preparation method and application thereof |
| 04/30/2014 | CN103751186A Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
| 04/30/2014 | CN102989006B Preparation method of silicon-nanowire-based medicinal carrier |
| 04/30/2014 | CN102824638B Medicinal composition containing zafirlukast and statins |
| 04/30/2014 | CN102369009B Co-crystal of etravirine and nicotinamide |
| 04/30/2014 | CN101925364B 14-3-3 antagonists for prevention and treatment of arthritis |
| 04/30/2014 | CN101843897B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 04/29/2014 | US8710229 Hepatitis C virus inhibitors |
| 04/29/2014 | US8710102 Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina |
| 04/29/2014 | US8710049 Diaminocyclohexane compounds and uses thereof |
| 04/29/2014 | US8710034 Method and composition for improving skin barrier function |
| 04/29/2014 | US8709498 Method of stimulating tissue healing |
| 04/29/2014 | US8709497 Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same |
| 04/29/2014 | US8709448 Anti-infective agents and uses thereof |
| 04/29/2014 | US8709447 Compositions and methods for activating innate and allergic immunity |
| 04/29/2014 | US8709430 Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids |
| 04/29/2014 | US8709425 Antibodies to non-functional P2X7 receptor |
| 04/29/2014 | US8709420 Pharmaceutical combination of pazopanib and topotecan to treat neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human |
| 04/29/2014 | US8709406 Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes |
| 04/29/2014 | CA2631931C Cancer therapies and pharmaceutical compositions used therein |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/24/2014 | WO2014063107A2 Stable peracid-containing compositions |
| 04/24/2014 | WO2014063057A1 Compositions and methods for the treatment of parkinson's disease |
| 04/24/2014 | WO2014061419A1 Novel cancer marker and utilization thereof |
| 04/24/2014 | WO2012106674A3 Using a cytokine signature to diagnose disease or infection |
| 04/24/2014 | US20140115727 NOVEL ANTI-cMET ANTIBODY |
| 04/24/2014 | US20140113969 Preventing And/Or Treating Cardiovascular Disease And/Or Associated Heart Failure |
| 04/24/2014 | US20140113953 Targeting MicroRNAs for Metabolic Disorders |
| 04/24/2014 | US20140113947 Pharmaceutical cream compositions of oxymetazoline and methods of use |
| 04/24/2014 | US20140113935 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 04/24/2014 | US20140113930 Therapeutic combination for cancer treatment |
| 04/24/2014 | US20140113921 Formulations of pyrimidinedione derivative compounds |
| 04/24/2014 | US20140113918 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| 04/24/2014 | US20140113917 Pyrazole compounds as crth2 antagonists |
| 04/24/2014 | US20140113908 [(1h-indol-5-yl) - heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders |
| 04/24/2014 | US20140113901 Imidazopyridazines as akt kinase inhibitors |
| 04/24/2014 | US20140113900 Substituted imidazopyridines and the use thereof |
| 04/24/2014 | US20140113896 Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines |
| 04/24/2014 | US20140113892 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/24/2014 | US20140113891 Compounds that inhibit human DNA ligases and methods of treating cancer |
| 04/24/2014 | US20140113886 Stabilized 1, 25-Dihydroxyvitamin D2 and Method of Making Same |
| 04/24/2014 | US20140113881 Antiinfective composition |
| 04/24/2014 | US20140113877 Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compounds |
| 04/24/2014 | US20140113865 Use of pertussis toxin as a therapeutic agent |
| 04/24/2014 | US20140113864 Injectable Depot Composition |
| 04/24/2014 | US20140113857 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9 |
| 04/24/2014 | US20140113012 Compounds and methods for inducing chondrogenesis |
| 04/24/2014 | US20140113008 Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage |
| 04/24/2014 | US20140113005 Compounds useful as inhibitors of atr kinase |
| 04/24/2014 | US20140113000 Compositions Comprising Peroxyacid and Methods for Producing and Using the Same |
| 04/24/2014 | US20140112983 Nitrite compositions and uses thereof |
| 04/24/2014 | US20140112976 Cyclic Peptides with an Anti-Neoplasic and Anti-Angiogenic Activity |
| 04/24/2014 | US20140112945 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives |
| 04/24/2014 | US20140112944 Compositions and methods for treating cancer |
| 04/24/2014 | US20140112942 Agonistic antibody to cd27 |
| 04/24/2014 | US20140112939 Methods for Inhibiting Osteolysis |
| 04/24/2014 | US20140112935 Antibodies to interleukin-6 and use thereof |
| 04/24/2014 | US20140112926 Fc VARIANTS |
| 04/24/2014 | US20140112920 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 04/24/2014 | US20140112919 Interleukin-10 antibodies |
| 04/24/2014 | US20140112911 Novel anti-cmet antibody |
| 04/24/2014 | US20140112909 Methods and formulations promoting tissue/organ regeneration, longevity and healthspan |
| 04/24/2014 | US20140112906 Prostatic Acid Phosphatase for the Treatment of Pain |
| 04/24/2014 | US20140112902 Methods for treatment of inflammatory and infectious diseases |
| 04/24/2014 | US20140112898 Unique population of regulatory t cells that regulate tissue regeneration and wound healing |
| 04/24/2014 | US20140112888 Viral Hepatitis Treatment |
| 04/24/2014 | US20140112887 2',4'-bridged nucleosides for hcv infection |
| 04/24/2014 | US20140112886 Dinucleotide compounds for hcv infection |
| 04/24/2014 | US20140112885 Antiviral compounds |
| 04/23/2014 | EP2722045A2 Compositions for treating centrally mediated nausea and vomiting |
| 04/23/2014 | EP2722044A1 Compositions for treating centrally mediated nausea and vomiting |
| 04/23/2014 | CN103736095A Chinese and western medicine combination preparation and application thereof to preparation of drugs for treating male and female reproduction diseases |
| 04/23/2014 | CN103736094A Methods and compositions for treating leukemia |
| 04/23/2014 | CN103736093A Medicinal preparation comprising mizolastine and steroid |
| 04/23/2014 | CN103736092A Method and medicament for inhibiting generation of neonatal lymphatic vessel |
| 04/23/2014 | CN103735511A Preparation method of magnetic drug-carrying liposome |
| 04/23/2014 | CN103735502A In-situ gel injection containing non-steroidal anti-inflammatory medicament/hydrogenated castor oil |
| 04/23/2014 | CN103735490A Method for preparing medicament sustained-release material |
| 04/23/2014 | CN102988989B Refining and extracting method of dextran by membrane separation |
| 04/23/2014 | CN102988986B Male trait induction method for pelodiscus sinensis in embryonic periods |
| 04/23/2014 | CN102977384B Modification method and application of cellulosa-imitating film structure of polylactic acid nano-particle surface |